🟢 Marker Therapeutics is trading 5.8% up in after-hours trading amid a biotech-sector rally

Marker Therapeutics is trading at $1.04, up 5.81%, with biotech-sector strength the likeliest explanation, not a confirmed company-specific catalyst.

• It closed November 3 at $0.98, up 9.08% in regular trading; the after-hours quote is 5.81% above the close.
• No November 3 headlines appeared in checked sources: Schwab reported none, and Market Chameleon listed no current headlines.
• XBI was up 2.13% in supplied context; Nasdaq data also showed it higher during November 3 trading.